background pattern
life science

Biotech & Pharmaceuticals

Computational platform for molecular design and discovery

Designing the drugs of tomorrow demands a predict-first approach

Running modern drug discovery programs is full of challenges. For more than 30 years, Schrödinger has enabled biotech and pharmaceutical teams worldwide with a computational platform for molecular design and discovery.

20

of the Top 20 Pharma companies use Schrödinger

750+

Companies license Schrödinger software worldwide

Software and services to support a diverse range of commercial organizations

Enterprise-grade deployments for large global enterprises

Scalable solutions for growing drug discovery organizations

Customizable packages for biotech startups

dark theme background
Morphic Therapeutic leverages digital chemistry strategy to design a novel small molecule inhibitor of α4β7 integrin

Morphic Therapeutic leverages digital chemistry strategy to design a novel small molecule inhibitor of α4β7 integrin

In this case study, we describe how Morphic Therapeutic, experts in all things integrin, partnered with Schrödinger’s drug discovery team to design an orally bioavailable drug selectively targeting α4β7 integrin to treat inflammatory bowel disease.

read the case study

Software and services to meet your organizational needs

Software Platform

Deploy digital drug discovery workflows using a comprehensive and user-friendly platform for molecular modeling, design, and collaboration.

Research Services

Leverage Schrödinger’s computational expertise and technology at scale to advance your projects through key stages in the drug discovery process.

Support & Training

Access expert support, educational materials, and training resources designed for both novice and experienced users.